South Korea is raising the alarm after the nation’s surging excess deaths have been linked to severe adverse events caused by Covid mRNA “vaccines.”
The alert was issued after the South Korean government published the findings of a bombshell new study on skyrocketing mortality rates among the Covid-vaccinated.
The study was conducted by leading scientists at the nation’s equivalent of the U.S. CDC, the Gyeonggi Infectious Disease Control Center (GIDCC).
The GIDCC’s Dr. Min Cheol Song led a team of researchers who hypothesized that the mortality rates are soaring among patients who experienced severe serious adverse events (SAEs) following a Covid “vaccination.”
The researchers investigated patients to see if mortality rates differ depending on whether they received a homologous (same vaccine platform) or heterologous (mix-and-match) prime-boost regimen.
The study was titled “Mortality in Severe Serious Adverse Events Following Heterologous and Homologous Prime-Boost Vaccination Strategies for SARS-CoV-2: A Retrospective Cohort Study.”
The results of the study have just been published in the medical journal PLOS One.
This retrospective cohort study analyzed 358 cases of severe SAEs temporally linked to Covid “vaccines” in South Korea’s Gyeonggi Province.
The researchers analysed official government data from February 2021 to March 2022.
Patients were grouped by vaccination strategy: homologous mRNA (n=220), homologous viral vector (n=75), and heterologous vector/mRNA (n=63).
Only patients who had received two or more doses were included.
Severe SAEs were defined as events resulting in death, ICU admission, life-threatening outcomes, permanent sequelae, or predefined adverse events of special interest.
The study assessed 42-day mortality risk and SAE etiology across the three vaccine strategy groups.
Patients in the heterologous group faced a 72% higher risk of death within 42 days of a severe adverse event compared to those who received homologous viral vector vaccines.
This group also showed significantly more deaths from respiratory (40.9%) and genitourinary (13.6%) conditions.
Mortality was lower among patients vaccinated at centralized centers than among those vaccinated at hospitals or long-term care facilities.
Notably, the heterologous group had more underlying conditions, including stroke, thyroid disorders, and chronic kidney disease.
This large provincial dataset reveals an elevated 42-day mortality risk among patients who experienced severe SAEs following heterologous prime-boost vaccination with a viral vector followed by mRNA.
Notably, deaths due to respiratory and genitourinary causes were disproportionately higher in this group.
This finding prompts questions about immunological overactivation or transient immune suppression post-vaccination.
The researchers warn that these findings underscore the need for risk stratification, especially in vulnerable populations like the elderly or those with pre-existing conditions.
While heterologous vaccination has been shown in multiple trials to enhance immunogenicity, this study suggests it may also raise safety concerns for certain subgroups.
Further investigation into biological mechanisms, such as lymphopenia and hyperreactivity, is warranted.
Renowned McCullough Foundation epidemiologist Nicolas Hulscher also weighed in on the findings in a post on Substack.
Hulscher warns that the study reveals a “44.7% case-fatality rate within 42 days for serious COVID-19 vaccine injuries.”
He notes that deaths and SRAs are the “highest” in mix-and-match recipients and long-term care patients.
Out of 358 patients who suffered severe SAEs post-vaccination, 160 died within 42 days, yielding a 42-day case-fatality rate of 44.7%.
Breaking down the data by vaccine strategy, Hulscher notes:
- Heterologous “Mix n’ Match” (viral vector + mRNA): 36 deaths / 63 cases = 57.1% mortality
- Homologous viral vector: 34 deaths / 75 cases = 45.3%
- Homologous mRNA (Pfizer/Moderna): 90 deaths / 220 cases = 40.9%
Hulscher also explains that the findings reveal how “vaccine” sites are linked to increased death risk.
Patients vaccinated outside of centralized vaccination centers experienced significantly higher mortality after severe SAEs:
- Medical institutions (e.g., clinics/hospitals):
- aHR: 2.776 — Nearly 3x higher mortality
- Nursing homes / long-term care:
- aHR: 4.374 — Over 4x higher mortality
- Community health centers:
- aHR: 3.945 — Nearly 4x higher mortality
According to this Korean government-backed study, around 45% of those individuals may die within 42 days.
Hulscher notes that the study supports the conservative Covid “vaccine” death estimate of 470,000–600,000 Americans who received a Pfizer mRNA injection.
As Slay News previously reported, the head of Florida’s Department of Health, Surgeon General Joseph Ladapo, recently revealed that Pfizer’s Covid mRNA “vaccine” killed over 470,000 Americans.
The alarming finding was revealed in Florida’s official data.
Florida’s Health Department collaborated with scientists from the world-renowned Massachusetts Institute of Technology (MIT) to investigate surges in all-cause mortality rates in the state.
The researchers found that Pfizer’s mRNA “vaccine” in particular caused dramatic increases in deaths from all causes, including COVID-19, non-Covid, and cardiovascular.
Alarmingly, the study confirmed that Covid mRNA “vaccines” triggered a global surge in all-cause mortality rates.
The study found that people who got the Pfizer vaccine had a stunning 36% increase in their all-cause mortality when compared to those who received Moderna’s mRNA injection.
This increased risk lasts for at least a year after the “vaccine” was administered.
Yet, this risk was not an increase from the baseline, as all-cause mortality also spiked among those who received the Moderna “vaccines.”
The investigation was a retrospective, matched cohort study involving 1,470,100 noninstitutionalized adult Florida residents.
READ MORE – Global Study: Covid Caused Zero Excess Deaths, mRNA Shots Caused Millions
